Rep. Leitner urges prioritizing generics in Medicaid to cut drug costs; fiscal office warns rebate trade-offs Representative Leitner urged committee approval of HB 4839 to prioritize generics and biosimilars in Medicaid, citing sample savings; House Fiscal said Michigan pays roughly $4.1 billion in pharmacy costs with $2.4 billion in rebates and estimated gross savings of $5000 million but noted lost rebates could reduce net savings.

Michigan's Medicaid program could save up to $100 million by prioritizing generics and biosimilars, but the trade-offs in rebates raise tough questions for lawmakers.

Learn more here

#MI #CitizenPortal #GenericDrugPolicy #PharmaceuticalReform #HealthcareCosts

Administration says most-favored-nation agreements will sharply lower U.S. drug prices At a Cabinet meeting the president announced what he called a most-favored-nation policy and said drugmakers agreed to prices that will cut many U.S. prescription costs; the Health official present said 16 of 17 companies have reached agreements and rural health funding will support access.

The president's new "most-favored-nation" policy promises to slash U.S. drug prices to the lowest rates globally, with major pharmaceutical companies on board.

Get the details!

#US #DrugPriceTransparency #PharmaceuticalReform #RuralHealthAccess #USHealth #CitizenPortal

Doctor Papoian discusses 340B program impact on healthcare costs and provider consolidation Doctor Papoian highlights 340B program issues including rising costs and reduced provider independence.

The Kansas Legislature is grappling with the unintended consequences of the 340B drug pricing program, which may be driving up healthcare costs and stifling independent practices.

Learn more here

#KS #CitizenPortal #HealthcareAccess #CostTransparency #PharmaceuticalReform #KansasHealthcare

Kansas Healthcare Leaders Examine 340B Pharmacy Contract Issues and Patient Cost Transparency Officials discuss transparency gaps in Kansas' 340B drug pricing program impacting patient savings.

Kansas lawmakers are tackling the urgent issue of pharmacy deserts and the shocking reality that only 1.4% of savings from the 340B drug pricing program actually benefit consumers.

Get the details!

#KS #CitizenPortal #HealthcareAccess #PatientTransparency #PharmaceuticalReform #KansasPharmacy

PHRMA and Healthcare Leaders Call for 340B Program Transparency Reform in Kansas Caitlin Lucarello and Sean Gravenger urge federal reforms for Kansas' 340B drug pricing program.

Healthcare leaders in Kansas are demanding urgent reforms to the controversial 340B drug pricing program, citing its impact on costs for patients and employers.

Learn more here!

#KS #CitizenPortal #HealthcareTransparency #PharmaceuticalReform #PatientAccess #KansasHealthcare

Indiana Senate Enacts SB 118 for 340B Program Transparency and Accountability Indiana's SB 118 mandates data reporting for 340B program to enhance transparency.

Kansas lawmakers are grappling with the urgent question of how to best allocate federal funds to support patients in need while navigating the complexities of healthcare reform.

Click to read more!

#KS #CitizenPortal #TransparencyInGovernment #PharmaceuticalReform #HealthcareFunding

Why should you write a letter to your Senators each week demanding #PharmaceuticalReform?

Action is completely up to you. Threaten Senators with voting for alternate candidates if necessary.

Reforms recommended for pharmaceutical sector Reforms recommended for pharmaceutical sector NBC Online Mon, 06/23/2025 - 18:58

#PharmaceuticalReform #MedicineSafety #PharmaIndustry #HealthcareRegulation #NamibiaHealth

Donald Trump pledges to cut US prescription drug prices by 80pc - Yes Punjab News Trump signs executive order to cut US prescription drug prices by 30-80%. Aimed at bringing fairness and reducing healthcare costs for Americans.

Donald Trump pledges to cut US prescription drug prices by 80pc yespunjab.com?p=122665

#Trump #PrescriptionDrugs #HealthcareReform #USPharma #DrugPrices #PharmaceuticalReform #Medications #DrugPricing #MostFavouredNation #HealthCareCosts #CancerTreatment #TruthSocial

Panel discusses solutions for patient access to essential medications amid patent and legal challenges Panelists address legislative options for improving drug access for patients facing shortages.

The Louisiana Legislature is tackling the urgent crisis of medication access, confronting the challenges of drug shortages and patent laws that leave millions of patients in the lurch.

Read the full story

#LA #LouisianaHealthcare #CitizenPortal #PatientAccess #PharmaceuticalReform

Senate passes Stop Stalling Act to curb pharmaceutical abuse of patent processes Senate advances bill preventing drug companies from obstructing generic drug approvals.

The Senate is making bold moves to combat pharmaceutical giants' patent games, aiming to slash drug prices and boost competition for consumers.

Get the details!

#US #CitizenPortal #HealthcareAccess #USSenate #PharmaceuticalReform #ConsumerProtection

Minnesota updates drug price reporting requirements and public disclosure rules Minnesota mandates new drug price transparency for manufacturers and public postings.

Minnesota is taking a bold step towards affordable healthcare by introducing a groundbreaking bill that demands transparency in prescription drug pricing!

Learn more here

#MN #HealthcareTransparency #CitizenPortal #MinnesotaDrugPricing #PharmaceuticalReform #ConsumerProtection

Representative Mosier introduces substitute for Senate Bill 153 to protect 340B entities Committee adopts substitute bill restricting pharmaceutical discrimination against 340B covered entities.

Kentucky lawmakers have made a bold move to protect underserved communities by adopting new legislation that prohibits discrimination against 340B covered entities, but will it be enough?

Read the full story

#KY #HealthcareAccess #EquityInHealthcare #PharmaceuticalReform #CitizenPortal

Maryland House Bill 813 regulates pharmacy benefits managers and reimbursement policies House Bill 813 establishes rules for pharmacy benefits managers in Maryland's managed care organizations.

Maryland's House Bill 813 could revolutionize prescription drug access by ensuring pharmacies receive fair reimbursement, but will it lead to higher costs for consumers?

Click to read more!

#MD #CitizenPortal #HealthcareAccess #PharmaceuticalReform #EconomicStability #MarylandPharmacies

Maryland House debates pharmaceutical pricing amendments to protect small pharmacies House members discuss amendments aimed at safeguarding small pharmacies amidst pricing reforms.

Maryland lawmakers are grappling with the tough task of balancing drug pricing reforms while ensuring small pharmacies can survive and thrive in their communities.

Click to read more!

#MD #LocalBusinessSupport #MarylandPharmacies #PharmaceuticalReform #CitizenPortal #HealthcareAccess